Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China · Delayed Price · Currency is CNY 15.28
+0.19 (1.26%)
At close: Feb 3, 2026
SHE:300705 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 469 | 512.38 | 368.26 | 269.7 | 204.25 | 82.26 |
Depreciation & Amortization | 92.36 | 92.36 | 71.48 | 59.7 | 53.58 | 48.24 |
Other Amortization | 4.27 | 4.27 | 1.28 | 1.04 | 1.03 | 0.88 |
Loss (Gain) From Sale of Assets | - | - | -0.03 | - | -0.02 | - |
Asset Writedown & Restructuring Costs | 1.92 | 1.92 | 1.46 | 0.39 | 0.88 | 10.99 |
Loss (Gain) From Sale of Investments | -3.11 | -3.11 | -2.13 | -1.84 | -2.85 | - |
Provision & Write-off of Bad Debts | -3.93 | -3.93 | 7.59 | 12.77 | 5.36 | - |
Other Operating Activities | -77.03 | 25.81 | 18.27 | 24.37 | 31.78 | 5.25 |
Change in Accounts Receivable | 137.01 | 137.01 | -125.79 | -224.11 | -115.63 | -44.43 |
Change in Inventory | -91.25 | -91.25 | -24.06 | -32.1 | -76.92 | -23.99 |
Change in Accounts Payable | 48.91 | 48.91 | 112.06 | 138.62 | 100.75 | 76.66 |
Change in Other Net Operating Assets | 4.86 | 4.86 | 26.96 | 28.93 | - | -2.88 |
Operating Cash Flow | 600.15 | 746.36 | 431.19 | 268.99 | 190.87 | 149.99 |
Operating Cash Flow Growth | -7.09% | 73.10% | 60.30% | 40.93% | 27.25% | 65.30% |
Capital Expenditures | -474.98 | -397.87 | -426.82 | -413.38 | -125.93 | -78.35 |
Sale of Property, Plant & Equipment | 0.43 | 0.12 | 0.15 | 0.13 | 0.27 | 0.05 |
Cash Acquisitions | - | - | - | - | -6.43 | - |
Investment in Securities | -19.2 | -257.12 | - | -20 | -100 | - |
Other Investing Activities | 3.88 | 3.27 | 2.1 | 1.9 | 2.54 | - |
Investing Cash Flow | -498.22 | -651.6 | -424.58 | -431.35 | -229.56 | -78.31 |
Long-Term Debt Issued | - | 81.4 | 157.8 | 314.76 | 53.7 | 19.9 |
Total Debt Issued | 228.48 | 81.4 | 157.8 | 314.76 | 53.7 | 19.9 |
Long-Term Debt Repaid | - | -61.31 | -364.09 | -124.44 | -17.75 | -71.63 |
Total Debt Repaid | -34.78 | -61.31 | -364.09 | -124.44 | -17.75 | -71.63 |
Net Debt Issued (Repaid) | 193.7 | 20.09 | -206.29 | 190.32 | 35.95 | -51.73 |
Issuance of Common Stock | 25.15 | 19.17 | 381.06 | - | 270 | - |
Common Dividends Paid | -160.79 | -115.71 | -94.62 | -69.3 | -15.01 | -13.77 |
Dividends Paid | -160.79 | -115.71 | -94.62 | -69.3 | -15.01 | -13.77 |
Other Financing Activities | -98.55 | - | -6.61 | - | -7.38 | - |
Financing Cash Flow | -40.49 | -76.45 | 73.55 | 121.02 | 283.56 | -65.5 |
Net Cash Flow | 61.42 | 18.31 | 80.16 | -41.35 | 244.88 | 6.19 |
Free Cash Flow | 125.17 | 348.5 | 4.37 | -144.39 | 64.94 | 71.64 |
Free Cash Flow Growth | -46.71% | 7880.00% | - | - | -9.35% | - |
Free Cash Flow Margin | 4.10% | 11.89% | 0.16% | -6.21% | 3.99% | 7.32% |
Free Cash Flow Per Share | 0.24 | 0.71 | 0.01 | -0.31 | 0.14 | 0.16 |
Cash Income Tax Paid | 304.02 | 305.02 | 302.22 | 243.22 | 188.16 | 104.61 |
Levered Free Cash Flow | -135.28 | 78.8 | -254.91 | -323.85 | 0.51 | 4.51 |
Unlevered Free Cash Flow | -126.81 | 90.44 | -248 | -312.34 | 10.52 | 7.79 |
Change in Working Capital | 116.67 | 116.67 | -34.99 | -97.14 | -103.15 | 2.38 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.